Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone-Resistant Prostate Cancer”

183 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 183 results

Not applicableUnknownNCT02208583
What this trial is testing

Molecular Phenotype Changes and Personalized Treatment for CRPC

Who this might be right for
Hormone Refractory Prostate Cancer
Tianjin Medical University Cancer Institute and Hospital 150
Testing effectiveness (Phase 2)UnknownNCT00218205
What this trial is testing

Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Department of Veterans Affairs, New Jersey 28
Testing effectiveness (Phase 2)Study completedNCT01051570
What this trial is testing

Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Testing effectiveness (Phase 2)Study completedNCT00564928
What this trial is testing

Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmsCancer of the Prostate
Infinity Pharmaceuticals, Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT01450683
What this trial is testing

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Stanford University 4
Not applicableWithdrawnNCT02867345
What this trial is testing

PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Peking University
Early research (Phase 1)Looking for participantsNCT06801236
What this trial is testing

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Acerand Therapeutics (Hong Kong) Limited 67
Testing effectiveness (Phase 2)Ended earlyNCT01313559
What this trial is testing

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

Who this might be right for
Castrate Resistant Prostate CancerChemotherapy Naive Prostate CancerProstate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 6
Not applicableEnded earlyNCT02491411
What this trial is testing

Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaProstate Adenocarcinoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Early research (Phase 1)Ended earlyNCT01510288
What this trial is testing

Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Amsterdam UMC, location VUmc 28
Testing effectiveness (Phase 2)Looking for participantsNCT07005154
What this trial is testing

Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 218
Testing effectiveness (Phase 2)Study completedNCT04676607
What this trial is testing

SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 6
Testing effectiveness (Phase 2)Ended earlyNCT01000948
What this trial is testing

A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastasis
Aarhus University Hospital 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02807805
What this trial is testing

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 37
Early research (Phase 1)Study completedNCT01295632
What this trial is testing

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)

Who this might be right for
Advanced Cancer
Merck Sharp & Dohme LLC 65
Testing effectiveness (Phase 2)Study completedNCT01468532
What this trial is testing

Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT01240629
What this trial is testing

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Prostate CancerHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Southern California 43
Testing effectiveness (Phase 2)Looking for participantsNCT05720130
What this trial is testing

Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
AdvanCell Pty Limited 100
Not applicableActive Not RecruitingNCT07352748
What this trial is testing

Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa

Who this might be right for
Metastatic Prostate Cancer
Universita di Verona 30
Load More Results